Alon Ben-Noon
Chief Executive Officer, NeuroSense Therapeutics Ltd.
Companies
- NeuroSense Therapeutics Ltd.Chief executive officer Mar 30, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NeuroSense Therapeutics Ltd. NRSN4,534,233 shares2$11.7M at $2.59Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Bought 250,000 shares at $0.80 of NeuroSense Therapeutics Ltd.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2